Byron Hann

6PUBLICATIONS
46CO-AUTHORS
Molecular targetsPredictive and prognostic markersMolecular imaging (incl. electron microscopy and neutron diffraction)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 09, 2022
Ferrous iron-activatable drug conjugate achieves potent MAPK blockade in KRAS-driven tumors.

Honglin Jiang, Ryan K Muir, Ryan L Gonciarz

|Sep 12, 2020
Potent Activity of an Anti-ICAM1 Antibody-Drug Conjugate against Multiple Myeloma.

Daniel W Sherbenou, Yang Su, Christopher R Behrens

|May 30, 2019
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies.

Kevin Lou, Veronica Steri, Alex Y Ge

|May 04, 2018
Development of a stress response therapy targeting aggressive prostate cancer.

Hao G Nguyen, Crystal S Conn, Yae Kye

Pageof 1